Show simple item record

dc.creatorMartin, Paul A.en
dc.creatorThomas, Sandra M.en
dc.date.accessioned2011-07-12T18:35:12Zen
dc.date.available2011-07-12T18:35:12Zen
dc.date.created1998-01-01en
dc.date.issued1998-01-01en
dc.identifier.bibliographicCitationHuman Gene Therapy 1998 January 1; 9(1): 87-114en
dc.identifier.urihttp://hdl.handle.net/10822/532500en
dc.descriptionChapters 5 and 6 of the STEEP Special Report #5, Science Policy Research Unit, University of Sussex, Brighton, United Kingdomen
dc.formatArticleen
dc.languageengen
dc.source186349en
dc.subjectGene Therapyen
dc.subject.classificationScience, Technology, and Societyen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationGene Therapy / Gene Transferen
dc.subject.classificationGenome Mappingen
dc.subject.classificationHuman Experimentationen
dc.subject.classificationBusiness Ethicsen
dc.titleThe commercial development of gene therapy in Europe and the USAen
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2019 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885